The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Nature

Volumn 486, Issue 7403, 2012, Pages 346-352

  Curtis, Christina ^a,b,h,m,o   Shah, Sohrab P ^c,d,e,n   Chin, Suet Feung ^a,b,h,m   Turashvili, Gulisa ^c,d,e,n   Rueda, Oscar M ^a,b,h,m   Dunning, Mark J ^b,h   Speed, Doug ^b,e,h,j,p   Lynch, Andy G ^a,b,h,m   Samarajiwa, Shamith ^a,b,h,m   Yuan, Yinyin ^a,b,h,m   Gräf, Stefan ^a,b,h,m   Ha, Gavin ^c,e   Haffari, Gholamreza ^c,e   Bashashati, Ali ^c,e   Russell, Roslin ^b,h   McKinney, Steven ^c,d,e,n   Aparicio, Samuel ^c,d,e,n   Brenton, James D ^b,h,m   Ellis, Ian ^g,o   Huntsman, David ^e,n   Pinder, Sarah ^e,i   Murphy, Leigh ^j,n   Bardwell, Helen ^h   Ding, Zhihao ^h   Jones, Linda ^o   Liu, Bin ^h,m   Papatheodorou, Irene ^h,m   Sammut, Stephen J ^h   Wishart, Gordon ^h   Chia, Steven ⁿ   Gelmon, Karen ⁿ   Speers, Caroline ⁿ   Watson, Peter ^c,d,e,j,n,o   Blamey, Roger ^o   Green, Andrew ^g,o   MacMillan, Douglas ^o   Rakha, Emad ^o   Gillett, Cheryl ^e   Grigoriadis, Anita ^e   De Rinaldis, Emanuele ^e   Tutt, Andy ^e   Parisien, Michelle ⁿ   Troup, Sandra ⁿ   Chan, Derek ^m   Fielding, Claire ^h   Maia, Ana Teresa ^h,m   McGuire, Sarah ^h   Osborne, Michelle ^h   Sayalero, Sara M ^h   Spiteri, Inmaculada ^h   Hadfield, James ^h   Bell, Lynda ⁿ   Chow, Katie ⁿ   Gale, Nadia ⁿ   Kovalik, Maria ⁿ   Ng, Ying ⁿ   Prentice, Leah ⁿ   Tavaré, Simon ^{a,b,e,h,m,n,o}   Markowetz, Florian ^a,b,h,m   Langerød, Anita ^f   Provenzano, Elena ^h   Purushotham, Arnie ^e,i,k   Børresen Dale, Anne Lise ^f,l   Caldas, Carlos ^a,b,h,m   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF MANITOBA   (Canada)

^k GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^l UNIVERSITY OF OSLO   (Norway)

^m Cambridge Experimental Cancer Medicine Centre   (United Kingdom)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN RECEPTOR; RNA; TRANSCRIPTOME;

GENE EXPRESSION; GENOMICS; MOLECULAR ANALYSIS; TUMOR;

ADAPTIVE IMMUNITY; ARTICLE; BREAST CANCER; CANCER GENETICS; CHROMOSOME 11Q; CHROMOSOME DELETION 5; COPY NUMBER VARIATION; DNA DETERMINATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FOLLOW UP; GENE DELETION; GENE EXPRESSION; GENOME; GENOMICS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAP2K4 GENE; MTAP GENE; PPP2R2A GENE; PRIORITY JOURNAL; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TUMOR GENE; VALIDATION STUDY;

BREAST NEOPLASMS; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENOME, HUMAN; GENOMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MAP KINASE KINASE 4; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROTEIN PHOSPHATASE 2; TREATMENT OUTCOME;

EID: 84861527388     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10983     Document Type: Article

References (29)

1. Leary, R. J. et al. Integrated analysis of homozygous deletions, focalamplifications, andsequence alterations in breastandcolorectal cancers. Proc.Natl Acad. Sci.USA 105, 16224-16229 (2008).
2. Bignell, G. R. et al. Signatures of mutation and selection in the cancer genome. Nature 463, 893-898 (2010).
3. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
4. Sørlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869-10874 (2001). (Pubitemid 32878711)
5. Chin, K. et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10, 529-541 (2006). (Pubitemid 44854748)
6. Chin, S. F. et al. High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol. 8, R215 (2007).
7. Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160-1167 (2009).
8. Stranger, B. E. et al. Genome-wide associations of gene expression variation in humans. PLoS Genet. 1, e78 (2005).
9. Gilad, Y., Rifkin, S. A.&Pritchard, J. K. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet. 24, 408-415 (2008).
10. Teschendorff, A. E., Naderi, A., Barbosa-Morais, N. L. & Caldas, C. PACK: Profile analysis using clustering and kurtosis to find molecular classifiers in cancer. Bioinformatics 22, 2269-2275 (2006). (Pubitemid 44390883)
11. Holland, D. et al. ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol. Med. 3, 167-180 (2011).
12. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997). (Pubitemid 27148818)
13. Santarius, T., Shiply, J., Brewer, D., Stratton, M. R. & Cooper, C. S. A census of amplified and overexpressed human cancer genes. Nature Rev. Cancer 10, 59-64 (2010).
14. Jones, S. et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330, 228-231 (2010).
15. McConechy, M. K. et al.Subtype-specificmutation ofPPP2R1A in endometrial and ovarian carcinomas. J. Pathol. 223, 567-573 (2011).
16. Tan, J. et al. B55b-associated PP2A complex controls PDK1-directed MYC signaling andmodulates rapamycin sensitivity in colorectal cancer. CancerCell18, 459-471 (2010).
17. Christopher, S. A., Diegelman, P., Porter, C. W.& Kruger, W. D.Methylthioadenosine phosphorylase, a gene frequently codeleted with p16 (CDKN2A/ARF), acts as a tumor suppressor in a breast cancer cell line. Cancer Res. 62, 6639-6644 (2002). (Pubitemid 35364132)
18. Teng, D. H. et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 57, 4177-4182 (1997). (Pubitemid 27413418)
19. Hollestelle, A. et al. Distinct genemutation profiles among luminal-type and basaltype breast cancer cell lines. Breast Cancer Res. Treat. 121, 53-64 (2010).
20. Shen, R., Olshen, A. B.&Ladanyi, M. Integrative clustering ofmultiple genomicdata types using a joint latent variablemodel with application to breast and lung cancer subtype analysis. Bioinformatics 25, 2906-2912 (2009).
21. Tibshirani, R., Hastie, T., Narasimhan, B. & Chu, G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl Acad. Sci. USA 99, 6567-6572 (2002). (Pubitemid 34526173)
22. Kapp, A. V. & Tibshirani, R. Are clusters found in one dataset present in another dataset? Biostatistics 8, 9-31 (2007). (Pubitemid 44906101)
23. Hughes-Davies, L. et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 115, 523-535 (2003). (Pubitemid 37506042)
24. Brown, L. A. et al.Amplification of 11q13 in ovarian carcinoma. Genes Chromosom. Cancer 47, 481-489 (2008). (Pubitemid 351657183)
25. Russnes, H. G. et al. Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci. Transl. Med. 2, 38ra47 (2010).
26. Blows, F. M. et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 7, e1000279 (2010).
27. Mahmoud, S. M. A. et al. Tumor-infiltrating CD81 lymphocytes predict clinical outcome in breast cancer. J. Clin. Oncol. 29, 1949-1955 (2011).
28. Daniel, J., Coulter, J., Woo, J.-H., Wilsbach, K. & Gabrielson, E. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc. Natl Acad. Sci. USA 108, 5384-5389 (2011).
29. Chen, Y. et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435 (2008). (Pubitemid 351450844)